Ayal Capital Advisors LTD Avid Bioservices, Inc. Transaction History
Ayal Capital Advisors LTD
- $227 Billion
- Q1 2024
A detailed history of Ayal Capital Advisors LTD transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Ayal Capital Advisors LTD holds 1,050,000 shares of CDMO stock, worth $7.79 Million. This represents 3.1% of its overall portfolio holdings.
Number of Shares
1,050,000Holding current value
$7.79 Million% of portfolio
3.1%Shares
1 transactions
Others Institutions Holding CDMO
# of Institutions
176Shares Held
64.8MCall Options Held
50.5KPut Options Held
102K-
State Street Corp Boston, MA5.85MShares$43.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.18MShares$38.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.4MShares$32.7 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$27.2 Million0.0% of portfolio
-
Altra Vue Capital, LLC Bellevue, WA3.16MShares$23.4 Million2.55% of portfolio
About Avid Bioservices, Inc.
- Ticker CDMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,167,500
- Market Cap $461M
- Description
- Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...